264 related articles for article (PubMed ID: 34474109)
1. Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
Henke LE; Stanley JA; Robinson C; Srivastava A; Contreras JA; Curcuru A; Green OL; Massad LS; Kuroki L; Fuh K; Hagemann A; Mutch D; McCourt C; Thaker P; Powell M; Markovina S; Grigsby PW; Schwarz JK; Chundury A
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):379-389. PubMed ID: 34474109
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.
Henke LE; Olsen JR; Contreras JA; Curcuru A; DeWees TA; Green OL; Michalski J; Mutic S; Roach MC; Bradley JD; Parikh PJ; Kashani R; Robinson CG
Adv Radiat Oncol; 2019; 4(1):201-209. PubMed ID: 30706029
[TBL] [Abstract][Full Text] [Related]
4. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
5. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
Schiff JP; Stowe HB; Price A; Laugeman E; Hatscher C; Hugo GD; Badiyan SN; Kim H; Robinson CG; Henke LE
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1022-1031. PubMed ID: 35768023
[TBL] [Abstract][Full Text] [Related]
6. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) for Abdominopelvic Oligometastases.
Yang DD; Brennan VS; Huynh E; Williams CL; Han Z; Ampofo N; Vastola ME; Sangal P; Singer L; Mak RH; Leeman JE; Cagney DN; Huynh MA
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):941-949. PubMed ID: 35598799
[TBL] [Abstract][Full Text] [Related]
8. Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART).
Lee G; Han Z; Huynh E; Tjong MC; Cagney DN; Huynh MA; Kann BH; Kozono D; Leeman JE; Singer L; Williams CL; Mak RH
Radiother Oncol; 2024 Jan; 190():110034. PubMed ID: 38030080
[TBL] [Abstract][Full Text] [Related]
9. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
10. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
11. SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes.
Regnery S; Buchele C; Piskorski L; Weykamp F; Held T; Eichkorn T; Rippke C; Katharina Renkamp C; Klüter S; Ristau J; König L; Koerber SA; Adeberg S; Debus J; Hörner-Rieber J
Radiother Oncol; 2022 Mar; 168():106-112. PubMed ID: 35121031
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.
Yoon SM; Luterstein E; Chu FI; Cao M; Lamb J; Agazaryan N; Low D; Raldow A; Steinberg ML; Lee P
Cancer Med; 2021 Sep; 10(17):5897-5906. PubMed ID: 34288538
[TBL] [Abstract][Full Text] [Related]
14. Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions.
Bryant JM; Cruz-Chamorro RJ; Gan A; Liveringhouse C; Weygand J; Nguyen A; Keit E; Sandoval ML; Sim AJ; Perez BA; Dilling TJ; Redler G; Andreozzi J; Nardella L; Naghavi AO; Feygelman V; Latifi K; Rosenberg SA
Commun Med (Lond); 2024 May; 4(1):96. PubMed ID: 38778215
[TBL] [Abstract][Full Text] [Related]
15. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Pfeffer MR; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Chuong MD
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):799-808. PubMed ID: 37210048
[TBL] [Abstract][Full Text] [Related]
16. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental Cohort.
Yim K; Hsu SH; Nolazco JI; Cagney D; Mak RH; D'Andrea V; Singer L; Williams C; Huynh E; Han Z; Martin N; Nguyen P; Kibel AS; Choueiri TK; Chang SL; Leeman JE
Eur Urol Oncol; 2024 Feb; 7(1):147-150. PubMed ID: 37487813
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.
Doty DG; Chuong MD; Gomez AG; Bryant J; Contreras J; Romaguera T; Alvarez D; Kotecha R; Mehta MP; Gutierrez AN; Mittauer KE
Med Dosim; 2021 Winter; 46(4):384-388. PubMed ID: 34120803
[TBL] [Abstract][Full Text] [Related]
19. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
20. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer.
Schiff JP; Price AT; Stowe HB; Laugeman E; Chin RI; Hatscher C; Pryser E; Cai B; Hugo GD; Kim H; Badiyan SN; Robinson CG; Henke LE
Radiother Oncol; 2022 Oct; 175():144-151. PubMed ID: 36063981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]